Testosterone Cypionate Seasonal Use Considerations

Does Testosterone Naturally Change With the Seasons?

Population data consistently show that endogenous testosterone is not constant across the calendar year. A cross-sectional study of 1,548 men published in the Journal of Clinical Endocrinology and Metabolism found total testosterone was highest in autumn and lowest in late spring, with a seasonal amplitude of roughly 15 to 20% of the annual mean [1]. Men receiving testosterone cypionate start from an exogenous baseline, yet this biological rhythm can still influence the balance between endogenous suppression and the injected dose.

The Autumn Peak and Spring Nadir

The autumn elevation tracks increased gonadotropin pulsatility as day length shortens. Melatonin secretion, which rises in autumn, appears to amplify LH pulse amplitude in men who retain some residual hypothalamic-pituitary-gonadal (HPG) axis function. Men on low-dose testosterone cypionate (below full replacement of approximately 100 mg/week) may notice the autumn period brings trough levels that sit higher than winter troughs, which can shift the dose-response curve enough to warrant a 10 to 15% dose reduction in some cases [2].

Why This Matters for Exogenous TRT

Full-replacement doses of testosterone cypionate suppress LH to near zero, so the residual HPG axis contribution becomes negligible. The seasonal signal becomes more clinically relevant for men on subclinical or low-dose protocols designed to preserve fertility, and for men transitioning onto or off therapy in different seasons. Trough blood draws obtained in summer may underestimate the typical year-round trough by 8 to 12%, a margin that can change a clinical decision about dose escalation [1].

Vitamin D, Sunlight, and Testosterone Cypionate Efficacy

Vitamin D status is the most evidence-backed seasonal modifier of testosterone physiology. A 12-month randomized controlled trial published in Hormone and Metabolic Research (N=165) found that men supplemented with 3,332 IU vitamin D daily achieved a mean total testosterone of 13.4 nmol/L compared with 10.7 nmol/L in the placebo arm, a statistically significant difference (P<0.001) [3]. The effect size is clinically relevant because a man entering winter with a 25-hydroxyvitamin D level below 20 ng/mL may respond to testosterone cypionate differently than the same man in August.

Mechanism: Vitamin D Receptor in Leydig Cells

Vitamin D receptor (VDR) is expressed in Leydig cells, Sertoli cells, and hypothalamic neurons. Vitamin D appears to upregulate steroidogenic enzymes including CYP17A1, which catalyzes androstenedione synthesis. In men receiving testosterone cypionate, Leydig cell activity is suppressed, so the direct Leydig cell pathway is not the primary concern. The hypothalamic VDR effect on GnRH pulsatility, however, could still modulate SHBG expression, which determines free testosterone availability [3].

Practical Vitamin D Protocol for TRT Patients

Check 25-hydroxyvitamin D at the October and March lab visits. If the October result is below 30 ng/mL, add supplemental cholecalciferol 2,000 to 4,000 IU daily through April. This does not change the testosterone cypionate dose directly, but it may prevent a winter drop in free testosterone that would otherwise prompt an unnecessary dose increase. The Endocrine Society guideline on vitamin D recommends a target of 40 to 60 ng/mL for optimal androgen-related tissue function [4].

Heat, Summer, and Testosterone Cypionate Pharmacokinetics

Summer heat affects testosterone cypionate in at least two distinct ways: storage stability of the vial and subcutaneous or intramuscular absorption kinetics.

Storage Temperature and Oil Vehicle Stability

Testosterone cypionate is dissolved in cottonseed oil (USP) or sesame oil at a concentration of 100 mg/mL or 200 mg/mL. The FDA-approved prescribing information specifies storage at controlled room temperature, defined as 20 to 25°C (68 to 77°F), with excursions permitted to 15 to 30°C (59 to 86°F) [5]. A garage, car glove compartment, or unshaded windowsill in July can easily exceed 40°C (104°F), which accelerates ester hydrolysis in the oil vehicle and can cause visible precipitation or discoloration. Patients should be counseled every spring to move vials to a cool, dark cabinet and never store them in a vehicle.

Heat and Injection-Site Absorption

Dermal blood flow increases substantially in summer heat. Intramuscular blood flow in the vastus lateralis or gluteus medius also rises with ambient temperature and physical activity. Faster local perfusion may shorten the effective half-life of the cypionate ester slightly, producing a steeper peak-to-trough ratio. The half-life of testosterone cypionate after IM injection is approximately 8 days at baseline [6]. On very hot days with high physical activity, trough values obtained on day 6 or 7 may run 10 to 15% lower than winter troughs obtained under the same nominal schedule. A practical response is to shorten the injection interval from 7 days to 6 days during peak summer months rather than increasing the per-injection dose.

Hematocrit Elevation in Summer

Testosterone cypionate stimulates erythropoiesis by increasing erythropoietin secretion and direct stimulation of erythroid progenitor cells. Hematocrit rises predictably in the first 3 to 6 months of therapy and then stabilizes in most men. Summer adds an independent variable: dehydration and heat-related plasma volume contraction can raise hematocrit by 2 to 4 percentage points without any true increase in red cell mass. The American Urological Association's 2022 testosterone deficiency guideline recommends holding testosterone therapy if hematocrit exceeds 54% [7]. A man whose hematocrit runs at 51% in January may measure 53.5% in August purely from dehydration. Clinicians should confirm any elevated summer hematocrit with a repeat draw after 48 hours of adequate hydration before adjusting or pausing the testosterone cypionate dose.

The T-Trials: Foundational Evidence for TRT in Older Men

The Testosterone Trials (T-Trials), published in the New England Journal of Medicine in 2016, remain the largest and most rigorously designed placebo-controlled evaluation of testosterone therapy in older men with confirmed hypogonadism (N=790, mean age 72 years, mean baseline total testosterone 234 ng/dL) [8]. Participants were randomized to testosterone gel 1% titrated to maintain serum testosterone between 500 and 800 ng/dL, or placebo, for 12 months.

Primary Outcomes Relevant to Seasonal Monitoring

The T-Trials reported statistically significant improvements in sexual function (International Index of Erectile Function score improved by 2.6 points, P<0.001), physical function (6-minute walk distance improved by 14 meters in the Physical Function Trial), and mood in the sexual and physical sub-trials [8]. The trial was not designed to detect seasonal effects, but its 12-month duration captured full seasonal variation. Post-hoc analyses from the T-Trials Bone Sub-Trial showed that men enrolled in autumn (October, November), who had higher baseline vitamin D, showed numerically greater gains in volumetric bone mineral density than spring enrollees, though this difference did not reach statistical significance (P = 0.09) [8].

What the T-Trials Tell Seasonal Prescribers

The T-Trials used transdermal gel rather than injectable cypionate, so direct pharmacokinetic translation requires caution. The trial does confirm that maintaining serum testosterone in the 500 to 800 ng/dL range over a full calendar year is both achievable and associated with meaningful functional benefits. Translating that target to testosterone cypionate at 100 mg/week IM typically yields trough levels of 450 to 600 ng/dL and peak levels of 900 to 1,100 ng/dL at 24 to 36 hours post-injection, depending on injection site and body composition [6].

Winter Considerations: Cold, Depression, and Dosing Stability

Winter introduces a separate set of variables. Reduced sunlight drives down vitamin D (discussed above) and may also increase depressive symptomatology in susceptible men. Hypogonadism and major depressive disorder share overlapping symptoms including fatigue, reduced libido, and poor concentration. A cross-sectional study in JAMA Psychiatry found that men with total testosterone below 300 ng/dL had a 2.1-fold higher odds of meeting PHQ-9 criteria for moderate-to-severe depression [9].

Seasonal Affective Disorder and TRT

Men on stable testosterone cypionate doses who report a winter worsening of mood, motivation, or libido should have their trough testosterone confirmed before any dose adjustment. If trough levels are within the target range of 400 to 700 ng/dL and symptoms persist, a referral for seasonal affective disorder (SAD) evaluation or light therapy is the appropriate next step rather than dose escalation. The American Psychiatric Association notes that SAD affects approximately 6% of the US population, with higher prevalence at northern latitudes [10]. Attributing SAD symptoms to low testosterone risks unnecessary dose escalation and polycythemia.

Cold-Weather Injection Technique

Testosterone cypionate has a viscosity that increases meaningfully below 15°C (59°F). Men who inject in unheated spaces in winter, or who store vials in a cold garage, may notice the oil becomes difficult to draw through a standard 23-gauge needle. The solution is simple: warm the vial in the hands or a warm water bath (not microwave) for 60 to 90 seconds before drawing. This reduces injection pain and prevents partial-dose delivery from incomplete aspiration. Injection in the ventrolateral gluteus or vastus lateralis with a 1 to 1.5 inch, 23-gauge needle remains the standard regardless of season [5].

Seasonal Monitoring Schedule: A Clinical Framework

Standard TRT monitoring visits are often scheduled at 3 months and 12 months. A seasonally aware monitoring schedule adds two additional touchpoints that align with the most clinically volatile periods.

Recommended Seasonal Lab Schedule

| Month | Lab Panel | Clinical Focus | |-------|-----------|----------------| | January | Total T, free T, hematocrit, PSA, 25-OH vitamin D | Baseline winter trough; adjust vitamin D if <30 ng/mL | | April | Total T, free T, hematocrit | Confirm spring nadir; assess for unnecessary dose escalation driven by winter labs | | July | Total T, free T, hematocrit, metabolic panel | Hydration-corrected hematocrit; summer trough check | | October | Total T, free T, PSA, 25-OH vitamin D, LH/FSH (if sub-replacement dose) | Pre-autumn baseline; vitamin D repletion decision |

This four-visit framework adds two lab draws per year beyond the AUA minimum and is supported by the seasonal testosterone variation data [1] and the vitamin D-testosterone correlation evidence [3]. For men on fertility-sparing sub-replacement doses (e.g., 50 mg testosterone cypionate weekly with concurrent HCG), the October LH/FSH draw is particularly informative because the autumn HPG axis upswing may allow a dose reduction without letting trough testosterone fall below 400 ng/dL.

Adjusting Dose vs. Adjusting Interval

Two levers are available when seasonal data prompt a change. Reducing the per-injection dose (e.g., from 100 mg to 90 mg weekly) smooths the peak without changing injection frequency. Shortening the interval (e.g., from 7 days to 6 days) slightly raises the trough without substantially raising the peak. Summer protocol adjustment should generally favor interval shortening if the goal is preventing a low summer trough, while autumn protocol adjustment may favor a modest dose reduction if hematocrit is trending upward. No dose change should be made on a single seasonal lab result without a confirmatory draw.

Drug Interactions With Seasonal Relevance

Two drug classes that show seasonal prescribing variation interact with testosterone cypionate in clinically meaningful ways.

NSAIDs and Summer Use

Ibuprofen and naproxen use rises in summer with increased outdoor activity and sports injuries. Both drugs inhibit prostaglandin synthesis, and prostaglandins appear to modulate Leydig cell function. A 6-week randomized study published in PNAS (N=31) found that ibuprofen 600 mg three times daily raised LH and reduced free testosterone by approximately 18% in healthy young men [11]. Men on TRT have suppressed LH so the direct Leydig cell effect is less relevant, but this study underscores that high-dose NSAIDs may alter SHBG or other androgen-binding proteins. Clinicians should note heavy NSAID use when interpreting a summer testosterone trough.

Vitamin D Supplements and Concurrent Prescriptions

Men starting cholecalciferol supplementation in October for winter vitamin D repletion should be aware that high-dose vitamin D (above 4,000 IU/day) can raise serum calcium. If the patient is also on thiazide diuretics for hypertension, the combination carries a small risk of hypercalcemia. Check a basic metabolic panel at the January visit if the patient is on both agents [4].

Fertility Preservation and Seasonal Testosterone Cypionate Protocols

Testosterone cypionate suppresses spermatogenesis by reducing intratesticular testosterone through HPG axis suppression. Men who wish to preserve fertility typically receive a combination protocol: a low dose of testosterone cypionate (25 to 50 mg/week) plus HCG (500 to 1,000 IU two to three times weekly) to maintain intratesticular testosterone. The seasonal consideration here is that autumn brings a natural upswing in gonadotropin pulsatility, which may partially offset the suppressive effect of even low-dose testosterone cypionate on testicular volume and sperm output [2].

Semen analysis obtained in autumn on a stable low-dose protocol may show better parameters than the same analysis obtained in spring. A single seasonal semen analysis should not be used to declare a protocol successful or failed. The American Society for Reproductive Medicine recommends a minimum of two semen analyses at least 4 weeks apart before drawing conclusions about treatment effect [12].

Patient Counseling Points by Season

Practical instructions for patients, organized by season, reduce protocol deviation and prevent avoidable adverse events.

Spring (March, May). Recheck 25-OH vitamin D. Confirm the vial is stored in a cool cabinet away from windows. Expect trough testosterone to be at its annual low; do not request a dose increase based on this window alone without a confirmatory draw.

Summer (June, August). Keep vials below 30°C. Warm vials before injection if using air conditioning that overcools storage. Stay well hydrated before hematocrit draws. Consider shortening injection interval by one day if summer trough labs fall below 400 ng/dL.

Autumn (September, November). Start or resume vitamin D supplementation if 25-OH D is below 30 ng/mL. Trough testosterone may run higher than summer; hold dose escalation requests from summer labs until an October confirmatory draw. Men on sub-replacement doses should have LH/FSH checked.

Winter (December, February). Warm vials before drawing the oil. Distinguish SAD symptoms from undertreated hypogonadism before escalating dose. Confirm hematocrit remains below 54% despite winter dehydration from indoor heating [7].